Validation of the multivariable In-hospital Mortality for PulmonAry embolism using Claims daTa (IMPACT) prediction rule within an all-payer inpatient administrative claims database

BMJ Open

Volumn 5, Issue 10, 2015, Pages

  Coleman, Craig I ^a   Kohn, Christine G ^b   Crivera, Concetta ^c   Schein, Jeffrey R ^c   Peacock, W Frank ^d  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b UNIVERSITY OF SAINT JOSEPH   (United States)

^c JANSSEN RESEARCH AND DEVELOPMENT   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BILLING AND CLAIMS; COMORBIDITY; FATALITY; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HIGH RISK PATIENT; HOSPITAL ADMISSION; HUMAN; LENGTH OF STAY; LOW RISK PATIENT; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEDICARE; MORTALITY; OUTCOME ASSESSMENT; PREDICTION; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; REFERENCE DATABASE; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; AGE; AGED; AREA UNDER THE CURVE; COMPLICATION; FACTUAL DATABASE; HOSPITAL MORTALITY; HOSPITALIZATION; MIDDLE AGED; PROCEDURES; PROGNOSIS; PULMONARY EMBOLISM; REPRODUCIBILITY; RISK ASSESSMENT; VALIDATION STUDY; VERY ELDERLY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; AREA UNDER CURVE; COMORBIDITY; DATABASES, FACTUAL; FEMALE; HEALTH CARE COSTS; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PULMONARY EMBOLISM; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 84949218796     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2015-009251     Document Type: Article

References (23)

1. Wiener RS, Schwartz LM, Woloshin S. Time trends in pulmonary embolism in the United States: evidence of overdiagnosis. Arch Intern Med 2011; 171: 831-7
2. Kearon C, Akl EA, Comerota AJ, et al., American College of Chest Physicians. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141: e419S-94S
3. Konstantinides SV, Torbicki A, Agnelli G, et al., Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 2014; 35: 3033-69
4. Kohn CG, Mearns ES, Parker MW, et al. Prognostic Accuracy of clinical prediction rules for early post-pulmonary embolism all-cause mortality: a bivariate meta-analysis. Chest 2015; 147: 1043-62
5. Aujesky D, Obrosky DS, Stone RA, et al. Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med 2005; 172: 1041-6
6. Jiménez D, Aujesky D, Moores L, et al., IETE Investigators. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med 2010; 170: 1383-9
7. Zondag W, den Exter PL, Crobach MJ, et al., Hestia Study Investigators. Comparison of two methods for selection of out of hospital treatment in patients with acute pulmonary embolism. Thromb Haemost 2013; 109: 47-52
8. Coleman CI, Kohn CG, Bunz TJ. Derivation and validation of the In-hospital Mortality for Pulmonary embolism using Claims Data (IMPACT) prediction rule. Curr Med Res Opin 201531: 1461-8
9. International Society for Pharmacoeconomics and Outcomes Research. International Digest of Databases. http://www.ispor.org/DigestOfIntDB/CountryList.aspx (last accessed on 8 Apr 2015
10. HCUP National Inpatient Sample (NIS). Healthcare Cost and Utilization Project (HCUP). Rockville, MD: Agency for Healthcare Research and Quality, 2012. http://www.hcup-us.ahrq.gov/nisoverview.jsp (last accessed on 10 Apr 2015
11. Steyerberg EW, Vickers AJ, Cook NR, et al. Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology 2010; 21: 128-38
12. Zondag W, Kooiman J, Klok FA, et al. Outpatient versus inpatient treatment in patients with pulmonary embolism: a meta-analysis. Eur Respir J 2013; 42: 134-44
13. Moons KG, Altman DG, Reitsma JB, et al. Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration. Ann Intern Med 2015; 162: W1-73
14. Erkens PM, Gandara E, Wells P, et al. Safety of outpatient treatment in acute pulmonary embolism. J Thromb Haemost 2010; 8: 2412-17
15. Kovacs MJ, Hawel JD, Rekman JF, et al. Ambulatory management of pulmonary embolism: a pragmatic evaluation. J Thromb Haemost 2010; 8: 2406-11
16. Baglin T. Fifty per cent of patients with pulmonary embolism can be treated as outpatients. J Thromb Haemost 2010; 8: 2404-5
17. Sharabiani MT, Aylin P, Bottle A. Systematic review of comorbidity indices for administrative data. Med Care 2012; 50: 1109-18
18. Gorham LW. A study of pulmonary embolism. II. The mechanism of death; based on a clinicopathological investigation of 100 cases of massive and 285 cases of minor embolism of the pulmonary artery. Arch Intern Med 1961; 108: 189-207
19. Dalen JE, Alpert JS. Natural history of pulmonary embolism. Prog Cardiovasc Dis 1975; 17: 259-70
20. Conget F, Otero R, Jiménez D, et al. Short-term clinical outcome after acute symptomatic pulmonary embolism. Thromb Haemost 2008; 100: 937-42
21. Miniati M, Monti S, Bottai M, et al. Survival and restoration of pulmonary perfusion in a long-term follow-up of patients after acute pulmonary embolism. Medicine (Baltimore) 2006; 85: 253-62
22. Vanni S, Nazerian P, Pepe G, et al. Comparison of two prognostic models for acute pulmonary embolism: clinical vs. right ventricular dysfunction guided approach. J Thromb Haemost 2011; 9: 1916-23
23. Palmieri V, Gallotta G, Rendina D, et al. Troponin I and right ventricular dysfunction for risk assessment in patients with nonmassive pulmonary embolism in the Emergency Department in combination with clinically based risk score. Intern Emerg Med 2008; 3: 131-8